Apollo, Siemens Healthineers Partner to Tackle Liver Disease with AI and Imaging Innovations

Apollo Hospitals and Siemens Healthineers have launched a strategic research collaboration to develop AI-driven and imaging-based solutions for improving liver disease management in India. The focus includes early detection, risk stratification, and monitoring of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), formerly known as NAFLD.

With prevalence estimates of MASLD ranging from 9% to 32%, particularly in obese, diabetic, or overweight individuals, the initiative addresses a growing public health challenge linked to rising cardiovascular risk.

Hariharan Subramanian of Siemens emphasized the potential of technology to improve diagnosis, awareness, and quality of life for liver disease patients.

The Master Research Agreement signed in March 2025 was followed by an Addendum signing on July 23, 2025, in Hyderabad, reinforcing the shared commitment to healthcare innovation.

28-07-2025